Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 26/Signature 1
From BugSigDB
Needs review
Source: Figure S5D
Description: The relative abundance in genus levels after cocktail treatment
Abundance in Group 1: increased abundance in D2.2 (gut microbiome remodeling compound)
NCBI | Quality Control | Links |
---|---|---|
Enterococcus |
Revision editor(s): Ifeanyisam